The top analyst upgrades, downgrades and other research calls from Monday include AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline and Square.
Tuesday's top analyst upgrades and downgrades included Broadcom, Ciena, Deere, FedEx, IMAX, Ironwood Pharmaceuticals, Lululemon Athletica, LyondellBasell Industries, Nvidia and Starbucks.
The top analyst upgrades, downgrades and initiations seen for Monday included Allscripts Healthcare Solutions, AmeriGas Partners, CVS Health, IMAX, Kraft Heinz, Marathon Oil, Microsoft and Pfizer.
Before U.S. markets open Thursday morning, 146 companies are scheduled to report quarterly earnings results. The following table is based on data from Briefing.com and includes a consensus forecast...
24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in hand, while others have pending FDA approval verdicts.
Has CrowdStrike CEO George Kurtz been increasing or decreasing his share count over the past year? Does he know something we don’t?
Morgan Stanley has downgraded its outlook for Crowdstrike to Equal-Weight.
Goldman Sachs has maintained coverage of CrowdStrike with a Buy recommendation.
Investors should look for companies that offer sturdy returns even after meeting all operating and non-operating costs.
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here. Upgrades: > easyJet (ESYJY) upgraded to Buy from Sell at Deutsche...
These four stocks are the top picks with a high net income ratio.
These are three top-ranked, high-quality businesses investors may want to consider buying on this pullback.
Quarterly results from large retailers will highlight this week’s earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well. This is especially...
Premarket futures inched back into the green to start a new week.